sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Diabetes Care Devices Market by Product (Blood Glucose Monitoring Devices and Insulin Delivery Devices) - Global Opportunity Analysis and Industry Forecasts, 2017-2023

Diabetes Care Devices Market by Product (Blood Glucose Monitoring Devices...

Home / Categories / Healthcare
Diabetes Care Devices Market by Product (Blood Glucose Monitoring Devices and Insulin Delivery Devices) - Global Opportunity Analysis and Industry Forecasts, 2017-2023
Diabetes Care Devices Market by...
Report Code
RO1/113/1235

Publish Date
01/Aug/2017

Pages
120
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.4.4. Impact analysis

3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL DIABETES CARE DEVICES MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. BLOOD GLUCOSE MONITORING DEVICES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Testing Strips

4.2.4.1. Market size and forecast

4.2.5. Self-monitoring Blood Glucose Meters

4.2.5.1. Market size and forecast

4.2.6. Lancets

4.2.6.1. Market size and forecast

4.2.7. Continuous Glucose Monitors

4.2.7.1. Market size and forecast

4.3. INSULIN DELIVERY DEVICES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Insulin Syringes

4.3.4.1. Market size and forecast

4.3.5. Insulin Pens

4.3.5.1. Market size and forecast

4.3.6. Insulin Pumps

4.3.6.1. Market size and forecast

4.3.7. Insulin Jet Injectors

4.3.7.1. Market size and forecast

CHAPTER 5 DIABETES CARE DEVICES MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S.
5.2.5. Canada
5.2.6. Mexico

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany
5.3.5. France
5.3.6. UK
5.3.7. Italy
5.3.8. Spain
5.3.9. Rest of Europe

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan
5.4.5. China
5.4.6. India
5.4.7. Australia
5.4.8. South Korea
5.4.9. Rest of Asia-Pacific

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Brazil
5.5.5. South Africa
5.5.6. Saudi Arabia
5.5.7. Rest of LAMEA

CHAPTER 6 COMPANY PROFILES

6.1. ABBOTT LABORATORIES

6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments

6.2. ACON LABORATORIES, INC.

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves and developments

6.3. ASCENSIA DIABETES CARE HOLDINGS AG

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Key strategic moves and developments

6.4. BECTON, DICKINSON AND COMPANY

6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves and developments

6.5. DEXCOM, INC.

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments

6.6. F. HOFFMANN-LA ROCHE LTD.

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments

6.7. JOHNSON & JOHNSON

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves and developments

6.8. MEDTRONIC PLC

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves and developments

6.9. NOVO NORDISK A/S

6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves and developments

6.10. TERUMO CORPORATION

6.10.1. Company overview
6.10.2. Operating business segments
6.10.3. Business performance
6.10.4. Key strategic moves and developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com